EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2001. Start Trial.
Date Value
June 30, 2023 -0.1108
March 31, 2023 -0.1235
December 31, 2022 -0.1033
September 30, 2022 -0.1199
June 30, 2022 -0.1344
March 31, 2022 -0.1395
December 31, 2021 -0.1307
September 30, 2021 -0.1207
June 30, 2021 -0.1271
March 31, 2021 -0.1536
December 31, 2020 -0.1649
September 30, 2020 -0.1576
June 30, 2020 -0.1649
March 31, 2020 -0.1898
December 31, 2019 -0.1995
September 30, 2019 -0.2002
June 30, 2019 -0.1846
March 31, 2019 -0.2414
December 31, 2018 -0.1444
September 30, 2018 0.2322
June 30, 2018 -0.12
March 31, 2018 -0.1822
December 31, 2017 -0.1437
September 30, 2017 -0.14
June 30, 2017 -0.34
Date Value
March 31, 2017 -0.2077
December 31, 2016 -0.46
September 30, 2016 -0.39
June 30, 2016 1.05
March 31, 2016 -0.82
December 31, 2015 -0.80
September 30, 2015 0.84
June 30, 2015 -0.78
March 31, 2015 -1.91
December 31, 2014 -0.83
September 30, 2014 2.03
June 30, 2014 -0.78
March 31, 2014 -0.87
December 31, 2013 -0.68
September 30, 2013 -0.71
June 30, 2013 -0.68
March 31, 2013 -0.57
December 31, 2012 -1.15
September 30, 2012 0.52
June 30, 2012 -0.54
March 31, 2012 -0.40
December 31, 2011 -0.52
September 30, 2011 -0.45
June 30, 2011 -0.44
March 31, 2011 -0.09

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
MabCure, Inc. --
Adynxx Inc --
OncoSec Medical, Inc. --
Proteonomix Inc --
Rebus Holdings Inc --